25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Nang Kuang Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyze Nang Kuang Pharmaceutical Co Ltd together

I guess you are interested in Nang Kuang Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nang Kuang Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Nang Kuang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nang Kuang Pharmaceutical Co Ltd.

1. Quick Overview

1.1. Quick analysis of Nang Kuang Pharmaceutical Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Nang Kuang Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.06
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
NT$22.51
Expected worth in 1 year
NT$21.60
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
NT$1.09
Return On Investment
2.5%

For what price can you sell your share?

Current Price per Share
NT$43.40
Expected price per share
NT$34.30 - NT$45.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Nang Kuang Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)
NT$43.40
Intrinsic Value Per Share
NT$-108.26 - NT$-16.43
Total Value Per Share
NT$-85.75 - NT$6.07

2.2. Growth of Nang Kuang Pharmaceutical Co Ltd (5 min.)




Is Nang Kuang Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$70.2m$73.6m-$1.8m-2.6%

How much money is Nang Kuang Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$854.7k$3.2m-$2.4m-282.2%
Net Profit Margin5.2%19.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Nang Kuang Pharmaceutical Co Ltd (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Nang Kuang Pharmaceutical Co Ltd?

Welcome investor! Nang Kuang Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Nang Kuang Pharmaceutical Co Ltd.

First you should know what it really means to hold a share of Nang Kuang Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Nang Kuang Pharmaceutical Co Ltd is NT$43.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nang Kuang Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nang Kuang Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$22.51. Based on the TTM, the Book Value Change Per Share is NT$-0.23 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nang Kuang Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.010.0%0.010.0%0.030.1%0.020.0%0.020.0%
Usd Book Value Change Per Share0.020.0%-0.010.0%0.010.0%0.000.0%0.010.0%
Usd Dividend Per Share0.000.0%0.020.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.020.0%0.010.0%0.030.1%0.020.0%0.020.0%
Usd Price Per Share1.68-1.63-1.72-1.40-1.30-
Price to Earnings Ratio31.08-11.20-13.90-17.24-21.81-
Price-to-Total Gains Ratio110.98--17.92-18.26-18.54--219.38-
Price to Book Ratio2.41-2.30-2.35-2.03-2.04-
Price-to-Total Gains Ratio110.98--17.92-18.26-18.54--219.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.34106
Number of shares745
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share0.010.02
Gains per Quarter (745 shares)6.2912.13
Gains per Year (745 shares)25.1848.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
146-2115371239
292-4240732488
3138-626511036137
4184-839014648186
5230-10411518360235
6276-12514021972284
7322-14616525684333
8368-16619029296382
9414-187215329108431
10460-208240365120480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%48.08.00.085.7%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%28.012.00.070.0%37.018.01.066.1%
Dividend per Share1.00.03.025.0%3.00.09.025.0%5.00.015.025.0%11.00.029.027.5%12.00.044.021.4%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%28.012.00.070.0%37.018.01.066.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Nang Kuang Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.489-0.226+146%0.470+4%0.130+276%0.217+125%
Book Value Per Share--22.50622.976-2%23.568-5%22.296+1%20.736+9%
Current Ratio--1.2141.212+0%1.558-22%1.391-13%1.439-16%
Debt To Asset Ratio--0.3740.378-1%0.333+12%0.347+8%0.357+5%
Debt To Equity Ratio--0.5980.607-1%0.501+19%0.533+12%0.565+6%
Dividend Per Share---0.499-100%0.388-100%0.397-100%0.339-100%
Eps--0.4370.273+60%1.042-58%0.578-24%0.501-13%
Free Cash Flow Per Share---1.174-0.269-77%1.030-214%0.419-380%0.393-399%
Free Cash Flow To Equity Per Share--0.148-0.900+710%0.571-74%0.064+131%0.054+172%
Gross Profit Margin--0.1630.678-76%0.630-74%0.490-67%0.263-38%
Intrinsic Value_10Y_max---16.433--------
Intrinsic Value_10Y_min---108.259--------
Intrinsic Value_1Y_max--1.106--------
Intrinsic Value_1Y_min---0.584--------
Intrinsic Value_3Y_max--1.225--------
Intrinsic Value_3Y_min---10.655--------
Intrinsic Value_5Y_max---1.185--------
Intrinsic Value_5Y_min---30.403--------
Market Cap4382879200.000-25%5486309100.0005336129335.950+3%5624949096.400-2%4596006532.395+19%4252378336.343+29%
Net Profit Margin--0.0860.052+65%0.190-55%0.119-28%0.116-26%
Operating Margin--0.1100.096+15%0.226-51%0.151-27%0.143-23%
Operating Ratio--0.8900.909-2%0.826+8%0.862+3%0.871+2%
Pb Ratio1.928-25%2.4132.295+5%2.349+3%2.029+19%2.036+18%
Pe Ratio24.839-25%31.07711.200+177%13.903+124%17.236+80%21.808+42%
Price Per Share43.400-25%54.30052.775+3%55.638-2%45.460+19%42.011+29%
Price To Free Cash Flow Ratio-9.242+20%-11.56334.176-134%-7.006-39%80.271-114%38.368-130%
Price To Total Gains Ratio88.702-25%110.980-17.925+116%18.257+508%18.538+499%-219.379+298%
Quick Ratio--0.5610.5620%0.732-23%0.678-17%0.818-31%
Return On Assets--0.0120.008+60%0.030-59%0.017-29%0.016-22%
Return On Equity--0.0190.012+60%0.044-56%0.026-25%0.024-20%
Total Gains Per Share--0.4890.273+79%0.858-43%0.527-7%0.556-12%
Usd Book Value--70265085.90071786686.875-2%73618562.475-5%69652182.855+1%64848349.118+8%
Usd Book Value Change Per Share--0.015-0.007+146%0.015+4%0.004+276%0.007+125%
Usd Book Value Per Share--0.6950.710-2%0.728-5%0.689+1%0.641+9%
Usd Dividend Per Share---0.015-100%0.012-100%0.012-100%0.010-100%
Usd Eps--0.0130.008+60%0.032-58%0.018-24%0.015-13%
Usd Free Cash Flow---3665172.600-839777.025-77%3216697.725-214%1308653.625-380%1227724.980-399%
Usd Free Cash Flow Per Share---0.036-0.008-77%0.032-214%0.013-380%0.012-399%
Usd Free Cash Flow To Equity Per Share--0.005-0.028+710%0.018-74%0.002+131%0.002+172%
Usd Market Cap135430967.280-25%169526951.190164886396.481+3%173810927.079-2%142016601.851+19%131398490.593+29%
Usd Price Per Share1.341-25%1.6781.631+3%1.719-2%1.405+19%1.298+29%
Usd Profit--1363771.500854786.700+60%3267319.650-58%1806851.235-25%1568090.025-13%
Usd Revenue--15829946.40016177169.692-2%16908008.775-6%14886566.308+6%13331977.267+19%
Usd Total Gains Per Share--0.0150.008+79%0.027-43%0.016-7%0.017-12%
 EOD+3 -5MRQTTM+22 -14YOY+5 -315Y+13 -2310Y+13 -23

3.3 Fundamental Score

Let's check the fundamental score of Nang Kuang Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.839
Price to Book Ratio (EOD)Between0-11.928
Net Profit Margin (MRQ)Greater than00.086
Operating Margin (MRQ)Greater than00.110
Quick Ratio (MRQ)Greater than10.561
Current Ratio (MRQ)Greater than11.214
Debt to Asset Ratio (MRQ)Less than10.374
Debt to Equity Ratio (MRQ)Less than10.598
Return on Equity (MRQ)Greater than0.150.019
Return on Assets (MRQ)Greater than0.050.012
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Nang Kuang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.414
Ma 20Greater thanMa 5043.233
Ma 50Greater thanMa 10043.620
Ma 100Greater thanMa 20044.751
OpenGreater thanClose43.750
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Nang Kuang Pharmaceutical Co Ltd

Nang Kuang Pharmaceutical Co., Ltd. engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan and internationally. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It also offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solutions. In addition, the company offers sterile, anticancer injectable, injectable controlled, and oral controlled products; and oral disintegration tablets. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Fundamental data was last updated by Penke on 2024-11-23 20:41:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Nang Kuang Pharmaceutical Co Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 8.6% means that NT$0.09 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 8.6%. The company is making a profit. +1
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.6%TTM5.2%+3.4%
TTM5.2%YOY19.0%-13.8%
TTM5.2%5Y11.9%-6.7%
5Y11.9%10Y11.6%+0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6%6.0%+2.6%
TTM5.2%4.8%+0.4%
YOY19.0%7.3%+11.7%
5Y11.9%7.0%+4.9%
10Y11.6%7.4%+4.2%
4.3.1.2. Return on Assets

Shows how efficient Nang Kuang Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • 1.2% Return on Assets means that Nang Kuang Pharmaceutical Co Ltd generated NT$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM0.8%+0.5%
TTM0.8%YOY3.0%-2.2%
TTM0.8%5Y1.7%-0.9%
5Y1.7%10Y1.6%+0.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%0.9%+0.3%
TTM0.8%0.8%0.0%
YOY3.0%1.5%+1.5%
5Y1.7%1.6%+0.1%
10Y1.6%1.6%0.0%
4.3.1.3. Return on Equity

Shows how efficient Nang Kuang Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • 1.9% Return on Equity means Nang Kuang Pharmaceutical Co Ltd generated NT$0.02 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 1.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.9%TTM1.2%+0.7%
TTM1.2%YOY4.4%-3.2%
TTM1.2%5Y2.6%-1.4%
5Y2.6%10Y2.4%+0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%1.9%+0.0%
TTM1.2%1.4%-0.2%
YOY4.4%2.7%+1.7%
5Y2.6%3.2%-0.6%
10Y2.4%3.0%-0.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Nang Kuang Pharmaceutical Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Nang Kuang Pharmaceutical Co Ltd is operating .

  • Measures how much profit Nang Kuang Pharmaceutical Co Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 11.0% means the company generated NT$0.11  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 11.0%. The company is operating less efficient.
  • The TTM is 9.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.0%TTM9.6%+1.4%
TTM9.6%YOY22.6%-13.0%
TTM9.6%5Y15.1%-5.4%
5Y15.1%10Y14.3%+0.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0%7.0%+4.0%
TTM9.6%5.1%+4.5%
YOY22.6%10.7%+11.9%
5Y15.1%9.6%+5.5%
10Y14.3%9.1%+5.2%
4.3.2.2. Operating Ratio

Measures how efficient Nang Kuang Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are NT$0.89 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 0.890. The company is less efficient in keeping operating costs low.
  • The TTM is 0.909. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.890TTM0.909-0.019
TTM0.909YOY0.826+0.083
TTM0.9095Y0.862+0.047
5Y0.86210Y0.871-0.010
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8901.054-0.164
TTM0.9091.056-0.147
YOY0.8261.017-0.191
5Y0.8621.048-0.186
10Y0.8711.012-0.141
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Nang Kuang Pharmaceutical Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Nang Kuang Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.21 means the company has NT$1.21 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 1.214. The company is just able to pay all its short-term debts.
  • The TTM is 1.212. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.214TTM1.212+0.001
TTM1.212YOY1.558-0.346
TTM1.2125Y1.391-0.179
5Y1.39110Y1.439-0.048
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2142.119-0.905
TTM1.2122.306-1.094
YOY1.5582.494-0.936
5Y1.3912.649-1.258
10Y1.4392.642-1.203
4.4.3.2. Quick Ratio

Measures if Nang Kuang Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.56 means the company can pay off NT$0.56 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 0.561. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.562. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.561TTM0.5620.000
TTM0.562YOY0.732-0.170
TTM0.5625Y0.678-0.116
5Y0.67810Y0.818-0.140
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5611.076-0.515
TTM0.5621.194-0.632
YOY0.7321.241-0.509
5Y0.6781.482-0.804
10Y0.8181.640-0.822
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Nang Kuang Pharmaceutical Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Nang Kuang Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.37 means that Nang Kuang Pharmaceutical Co Ltd assets are financed with 37.4% credit (debt) and the remaining percentage (100% - 37.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 0.374. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.378. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.374TTM0.378-0.003
TTM0.378YOY0.333+0.045
TTM0.3785Y0.347+0.031
5Y0.34710Y0.357-0.011
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3740.371+0.003
TTM0.3780.360+0.018
YOY0.3330.345-0.012
5Y0.3470.365-0.018
10Y0.3570.376-0.019
4.5.4.2. Debt to Equity Ratio

Measures if Nang Kuang Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 59.8% means that company has NT$0.60 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The MRQ is 0.598. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.607. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.607-0.009
TTM0.607YOY0.501+0.106
TTM0.6075Y0.533+0.074
5Y0.53310Y0.565-0.031
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5980.560+0.038
TTM0.6070.563+0.044
YOY0.5010.532-0.031
5Y0.5330.599-0.066
10Y0.5650.655-0.090
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Nang Kuang Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Nang Kuang Pharmaceutical Co Ltd to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 31.08 means the investor is paying NT$31.08 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The EOD is 24.839. Based on the earnings, the company is fair priced.
  • The MRQ is 31.077. Based on the earnings, the company is overpriced. -1
  • The TTM is 11.200. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD24.839MRQ31.077-6.238
MRQ31.077TTM11.200+19.877
TTM11.200YOY13.903-2.702
TTM11.2005Y17.236-6.036
5Y17.23610Y21.808-4.572
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD24.83916.228+8.611
MRQ31.07715.996+15.081
TTM11.20015.924-4.724
YOY13.90319.454-5.551
5Y17.23621.819-4.583
10Y21.80824.302-2.494
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The EOD is -9.242. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.563. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 34.176. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-9.242MRQ-11.563+2.321
MRQ-11.563TTM34.176-45.739
TTM34.176YOY-7.006+41.182
TTM34.1765Y80.271-46.095
5Y80.27110Y38.368+41.903
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-9.24213.794-23.036
MRQ-11.56313.684-25.247
TTM34.1769.205+24.971
YOY-7.006-0.291-6.715
5Y80.2712.533+77.738
10Y38.368-1.544+39.912
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Nang Kuang Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.41 means the investor is paying NT$2.41 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Nang Kuang Pharmaceutical Co Ltd:

  • The EOD is 1.928. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.413. Based on the equity, the company is underpriced. +1
  • The TTM is 2.295. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.928MRQ2.413-0.484
MRQ2.413TTM2.295+0.117
TTM2.295YOY2.349-0.054
TTM2.2955Y2.029+0.267
5Y2.02910Y2.036-0.008
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.9282.454-0.526
MRQ2.4132.594-0.181
TTM2.2952.771-0.476
YOY2.3492.727-0.378
5Y2.0293.882-1.853
10Y2.0364.419-2.383
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in TWD. All numbers in thousands.

Summary
Total Assets3,634,682
Total Liabilities1,360,731
Total Stockholder Equity2,273,951
 As reported
Total Liabilities 1,360,731
Total Stockholder Equity+ 2,273,951
Total Assets = 3,634,682

Assets

Total Assets3,634,682
Total Current Assets1,420,505
Long-term Assets2,214,177
Total Current Assets
Cash And Cash Equivalents 244,648
Net Receivables 412,470
Inventory 741,892
Other Current Assets 21,495
Total Current Assets  (as reported)1,420,505
Total Current Assets  (calculated)1,420,505
+/-0
Long-term Assets
Property Plant Equipment 1,982,257
Long-term Assets Other 5,674
Long-term Assets  (as reported)2,214,177
Long-term Assets  (calculated)1,987,931
+/- 226,246

Liabilities & Shareholders' Equity

Total Current Liabilities1,170,322
Long-term Liabilities190,409
Total Stockholder Equity2,273,951
Total Current Liabilities
Short-term Debt 422,656
Short Long Term Debt 422,607
Accounts payable 192,388
Other Current Liabilities 427,053
Total Current Liabilities  (as reported)1,170,322
Total Current Liabilities  (calculated)1,464,704
+/- 294,382
Long-term Liabilities
Long term Debt 6,250
Capital Lease Obligations 95
Long-term Liabilities Other 30,100
Long-term Liabilities  (as reported)190,409
Long-term Liabilities  (calculated)36,445
+/- 153,964
Total Stockholder Equity
Common Stock1,009,885
Retained Earnings 640,892
Accumulated Other Comprehensive Income 297,371
Other Stockholders Equity 325,803
Total Stockholder Equity (as reported)2,273,951
Total Stockholder Equity (calculated)2,273,951
+/-0
Other
Capital Stock1,009,885
Cash and Short Term Investments 244,648
Common Stock Shares Outstanding 101,037
Current Deferred Revenue128,225
Liabilities and Stockholders Equity 3,634,682
Net Debt 284,304
Net Invested Capital 2,702,808
Net Working Capital 250,183
Property Plant and Equipment Gross 1,982,257
Short Long Term Debt Total 528,952



6.2. Balance Sheets Structured

Currency in TWD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-03-31
> Total Assets 
0
1,851,632
1,928,985
1,902,544
2,002,981
2,093,146
2,196,751
2,290,633
2,362,143
2,415,832
2,402,420
2,502,329
2,518,250
2,606,652
2,588,848
2,569,768
2,619,009
2,755,593
2,876,639
2,950,062
2,965,166
3,045,420
3,034,670
3,043,648
3,095,153
3,172,164
3,170,352
3,306,042
3,274,094
3,334,297
3,275,453
3,224,105
3,155,743
3,027,775
3,015,468
2,966,469
3,068,306
3,287,407
3,432,748
3,505,291
3,235,424
3,260,115
3,236,961
3,296,559
3,323,657
3,428,891
3,394,865
3,415,786
3,381,984
3,584,545
3,629,425
3,700,788
3,842,883
3,856,169
3,602,939
3,634,682
3,634,6823,602,9393,856,1693,842,8833,700,7883,629,4253,584,5453,381,9843,415,7863,394,8653,428,8913,323,6573,296,5593,236,9613,260,1153,235,4243,505,2913,432,7483,287,4073,068,3062,966,4693,015,4683,027,7753,155,7433,224,1053,275,4533,334,2973,274,0943,306,0423,170,3523,172,1643,095,1533,043,6483,034,6703,045,4202,965,1662,950,0622,876,6392,755,5932,619,0092,569,7682,588,8482,606,6522,518,2502,502,3292,402,4202,415,8322,362,1432,290,6332,196,7512,093,1462,002,9811,902,5441,928,9851,851,6320
   > Total Current Assets 
0
464,205
507,511
479,789
552,368
594,283
588,676
614,022
633,150
635,030
604,646
670,305
677,146
759,413
755,062
753,497
810,023
935,935
931,691
985,271
998,140
1,072,452
1,060,822
1,075,018
1,093,880
1,117,937
1,095,339
1,224,491
1,199,777
1,227,599
1,192,126
1,146,711
1,097,785
1,004,962
1,025,573
1,013,614
1,136,849
1,383,342
1,528,086
1,617,749
1,375,696
1,435,120
1,396,230
1,462,150
1,366,701
1,491,397
1,452,072
1,500,145
1,488,416
1,640,329
1,695,554
1,749,785
1,594,833
1,537,677
1,427,721
1,420,505
1,420,5051,427,7211,537,6771,594,8331,749,7851,695,5541,640,3291,488,4161,500,1451,452,0721,491,3971,366,7011,462,1501,396,2301,435,1201,375,6961,617,7491,528,0861,383,3421,136,8491,013,6141,025,5731,004,9621,097,7851,146,7111,192,1261,227,5991,199,7771,224,4911,095,3391,117,9371,093,8801,075,0181,060,8221,072,452998,140985,271931,691935,935810,023753,497755,062759,413677,146670,305604,646635,030633,150614,022588,676594,283552,368479,789507,511464,2050
       Cash And Cash Equivalents 
0
54,351
87,805
62,689
78,072
107,659
52,499
97,206
109,566
93,689
81,037
101,102
98,187
147,838
118,083
157,393
156,138
226,410
243,846
230,652
236,599
287,566
300,832
332,567
314,955
346,272
317,195
431,924
323,146
351,495
298,651
271,395
208,036
176,550
157,290
161,392
258,252
391,950
446,789
501,314
286,709
266,462
271,770
377,348
313,001
417,123
331,647
253,488
286,748
401,200
368,740
460,832
303,462
378,475
228,090
244,648
244,648228,090378,475303,462460,832368,740401,200286,748253,488331,647417,123313,001377,348271,770266,462286,709501,314446,789391,950258,252161,392157,290176,550208,036271,395298,651351,495323,146431,924317,195346,272314,955332,567300,832287,566236,599230,652243,846226,410156,138157,393118,083147,83898,187101,10281,03793,689109,56697,20652,499107,65978,07262,68987,80554,3510
       Short-term Investments 
0
22,181
19,698
19,925
17,736
16,829
18,170
17,679
18,161
17,788
19,255
20,014
21,330
22,554
21,947
22,684
21,539
23,839
24,158
24,505
23,674
24,036
22,947
23,906
25,726
25,012
25,727
27,131
33,141
29,125
28,849
30,802
29,781
1,477
1,509
1,586
1,653
1,569
1,606
1,606
1,629
1,392
1,317
1,308
1,310
1,284
1,273
1,197
1,224
1,310
-6,373
-6,343
-6,312
-6,281
-6,252
0
0-6,252-6,281-6,312-6,343-6,3731,3101,2241,1971,2731,2841,3101,3081,3171,3921,6291,6061,6061,5691,6531,5861,5091,47729,78130,80228,84929,12533,14127,13125,72725,01225,72623,90622,94724,03623,67424,50524,15823,83921,53922,68421,94722,55421,33020,01419,25517,78818,16117,67918,17016,82917,73619,92519,69822,1810
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
248,567
271,674
262,799
308,695
330,012
291,745
346,929
352,968
344,155
392,109
352,487
376,034
392,992
372,606
356,285
342,806
333,211
327,145
369,465
410,236
410,236
386,084
377,857
383,556
369,336
346,906
356,754
367,424
407,963
386,680
386,475
373,815
375,997
369,917
361,449
350,839
324,365
385,854
369,668
386,863
426,274
403,143
431,810
375,973
417,334
412,470
412,470417,334375,973431,810403,143426,274386,863369,668385,854324,365350,839361,449369,917375,997373,815386,475386,680407,963367,424356,754346,906369,336383,556377,857386,084410,236410,236369,465327,145333,211342,806356,285372,606392,992376,034352,487392,109344,155352,968346,929291,745330,012308,695262,799271,674248,5670000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
66,474
64,067
63,101
66,080
74,130
48,462
66,186
64,802
71,499
68,504
71,917
67,957
62,936
74,703
92,534
79,240
92,161
84,803
108,640
90,227
94,665
95,664
100,818
26,447
64,227
62,960
53,370
56,509
34,457
27,837
32,025
26,450
23,070
21,484
31,050
20,713
24,218
23,450
19,986
23,376
28,588
23,583
82,024
20,614
20,683
21,495
21,49520,68320,61482,02423,58328,58823,37619,98623,45024,21820,71331,05021,48423,07026,45032,02527,83734,45756,50953,37062,96064,22726,447100,81895,66494,66590,227108,64084,80392,16179,24092,53474,70362,93667,95771,91768,50471,49964,80266,18648,46274,13066,08063,10164,06766,4740000000000
   > Long-term Assets 
0
1,387,427
1,421,474
1,422,755
1,450,613
1,498,863
1,608,075
1,676,611
1,728,993
1,780,802
1,797,774
1,832,024
1,841,104
1,847,239
1,833,786
1,816,271
1,808,986
1,819,658
1,944,948
1,964,791
1,967,026
1,972,968
1,973,848
1,968,630
2,001,273
2,054,227
2,075,013
2,081,551
2,074,317
2,106,698
2,083,327
2,077,394
2,057,958
2,022,813
1,989,895
1,952,855
1,931,457
1,904,065
1,904,662
1,887,542
1,859,728
1,824,995
1,840,731
1,834,409
1,956,956
1,937,494
1,942,793
1,915,641
1,893,568
1,944,216
1,933,871
1,951,003
2,248,050
2,318,492
2,175,218
2,214,177
2,214,1772,175,2182,318,4922,248,0501,951,0031,933,8711,944,2161,893,5681,915,6411,942,7931,937,4941,956,9561,834,4091,840,7311,824,9951,859,7281,887,5421,904,6621,904,0651,931,4571,952,8551,989,8952,022,8132,057,9582,077,3942,083,3272,106,6982,074,3172,081,5512,075,0132,054,2272,001,2731,968,6301,973,8481,972,9681,967,0261,964,7911,944,9481,819,6581,808,9861,816,2711,833,7861,847,2391,841,1041,832,0241,797,7741,780,8021,728,9931,676,6111,608,0751,498,8631,450,6131,422,7551,421,4741,387,4270
       Property Plant Equipment 
0
1,338,492
1,372,574
1,372,302
1,402,123
1,458,883
1,568,688
1,639,063
1,691,377
1,744,556
1,733,726
1,777,263
1,785,782
1,791,473
1,769,708
1,757,187
1,743,511
1,725,856
1,825,108
1,824,283
1,820,913
1,818,408
1,831,549
1,829,215
1,856,078
1,928,401
1,947,830
1,951,178
1,949,410
1,963,729
1,929,999
1,917,230
1,939,880
1,917,466
1,877,606
1,863,820
1,832,914
1,805,598
1,772,534
1,747,152
1,727,097
1,701,713
1,728,956
1,728,924
1,721,362
1,699,244
1,679,406
1,653,786
1,627,407
1,623,866
1,601,146
1,584,106
1,898,268
1,949,898
1,951,307
1,982,257
1,982,2571,951,3071,949,8981,898,2681,584,1061,601,1461,623,8661,627,4071,653,7861,679,4061,699,2441,721,3621,728,9241,728,9561,701,7131,727,0971,747,1521,772,5341,805,5981,832,9141,863,8201,877,6061,917,4661,939,8801,917,2301,929,9991,963,7291,949,4101,951,1781,947,8301,928,4011,856,0781,829,2151,831,5491,818,4081,820,9131,824,2831,825,1081,725,8561,743,5111,757,1871,769,7081,791,4731,785,7821,777,2631,733,7261,744,5561,691,3771,639,0631,568,6881,458,8831,402,1231,372,3021,372,5741,338,4920
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
1,450
1,488
1,434
1,412
486
557
495
433
374
382
1,460
2,104
2,236
7,286
7,299
7,359
6,918
8,661
8,624
8,977
8,809
8,272
8,155
10,835
11,710
10,817
9,994
9,031
8,079
7,867
8,008
7,187
6,346
5,466
4,792
4,119
3,417
3,074
3,303
3,103
3,446
2,945
4,333
5,277
5,213
4,899
4,720
4,297
3,874
4,651
4,627
5,692
5,195
5,474
0
05,4745,1955,6924,6274,6513,8744,2974,7204,8995,2135,2774,3332,9453,4463,1033,3033,0743,4174,1194,7925,4666,3467,1878,0087,8678,0799,0319,99410,81711,71010,8358,1558,2728,8098,9778,6248,6616,9187,3597,2997,2862,2362,1041,4603823744334955574861,4121,4341,4881,4500
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204,501
62,675
220,793
67,227
0
0
0
0
000067,227220,79362,675204,501000000000000000000000000000000000000000000000000
> Total Liabilities 
0
1,048,273
1,112,464
1,090,844
1,194,336
1,290,802
1,374,299
1,452,556
1,500,797
1,487,808
1,117,825
1,247,264
1,231,627
1,181,058
1,168,203
1,174,064
1,194,847
1,314,195
1,342,379
1,416,181
1,194,848
1,051,102
973,621
1,042,479
1,045,627
1,049,024
982,101
1,243,857
1,178,127
1,191,082
1,094,593
1,174,770
1,096,497
974,638
926,873
956,717
998,122
1,100,129
1,182,522
1,383,382
1,084,125
1,055,586
987,649
1,154,571
1,136,241
1,188,684
1,113,636
1,241,730
1,133,325
1,173,516
1,124,484
1,335,506
1,430,979
1,479,066
1,373,122
1,360,731
1,360,7311,373,1221,479,0661,430,9791,335,5061,124,4841,173,5161,133,3251,241,7301,113,6361,188,6841,136,2411,154,571987,6491,055,5861,084,1251,383,3821,182,5221,100,129998,122956,717926,873974,6381,096,4971,174,7701,094,5931,191,0821,178,1271,243,857982,1011,049,0241,045,6271,042,479973,6211,051,1021,194,8481,416,1811,342,3791,314,1951,194,8471,174,0641,168,2031,181,0581,231,6271,247,2641,117,8251,487,8081,500,7971,452,5561,374,2991,290,8021,194,3361,090,8441,112,4641,048,2730
   > Total Current Liabilities 
0
290,212
354,273
396,059
463,254
578,122
668,499
565,619
630,962
573,834
494,741
478,866
495,450
264,133
281,161
302,615
323,014
454,410
509,407
598,888
550,449
620,927
565,155
989,506
992,914
786,949
723,822
1,011,602
945,897
979,928
891,638
997,952
920,814
821,894
777,208
830,136
873,880
985,460
1,067,998
1,294,782
995,532
950,029
882,054
1,055,232
1,035,311
1,072,954
997,787
1,132,567
992,983
1,040,393
992,346
1,209,004
1,304,183
1,282,690
1,176,360
1,170,322
1,170,3221,176,3601,282,6901,304,1831,209,004992,3461,040,393992,9831,132,567997,7871,072,9541,035,3111,055,232882,054950,029995,5321,294,7821,067,998985,460873,880830,136777,208821,894920,814997,952891,638979,928945,8971,011,602723,822786,949992,914989,506565,155620,927550,449598,888509,407454,410323,014302,615281,161264,133495,450478,866494,741573,834630,962565,619668,499578,122463,254396,059354,273290,2120
       Short-term Debt 
0
97,897
163,360
195,092
257,851
91,820
160,862
180,862
205,663
236,004
324,613
162,458
351,016
140,478
152,728
147,557
165,041
270,942
354,533
407,096
318,835
400,227
387,890
659,970
769,996
552,310
518,851
532,566
628,922
631,907
482,991
401,469
458,951
372,190
307,896
259,127
368,482
424,838
490,593
485,992
451,063
381,067
385,939
407,911
494,011
494,490
474,165
454,118
453,888
383,912
377,991
436,106
584,386
593,395
282,873
422,656
422,656282,873593,395584,386436,106377,991383,912453,888454,118474,165494,490494,011407,911385,939381,067451,063485,992490,593424,838368,482259,127307,896372,190458,951401,469482,991631,907628,922532,566518,851552,310769,996659,970387,890400,227318,835407,096354,533270,942165,041147,557152,728140,478351,016162,458324,613236,004205,663180,862160,86291,820257,851195,092163,36097,8970
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
493,226
472,905
452,895
452,660
382,866
376,972
435,171
583,672
592,903
282,604
422,607
422,607282,604592,903583,672435,171376,972382,866452,660452,895472,905493,226000000000000000000000000000000000000000000000
       Accounts payable 
0
17,823
21,790
18,600
21,041
22,654
15,210
15,805
14,998
13,493
98,687
17,084
30,640
28,332
57,604
40,921
31,268
54,147
30,837
27,536
51,637
69,897
38,609
51,681
75,777
63,402
51,477
46,674
51,843
69,413
119,337
138,633
159,870
150,293
195,664
164,797
195,731
225,968
244,110
254,624
148,063
187,597
128,848
131,229
159,022
223,607
157,113
143,991
146,819
253,934
257,589
198,026
175,875
166,401
209,252
192,388
192,388209,252166,401175,875198,026257,589253,934146,819143,991157,113223,607159,022131,229128,848187,597148,063254,624244,110225,968195,731164,797195,664150,293159,870138,633119,33769,41351,84346,67451,47763,40275,77751,68138,60969,89751,63727,53630,83754,14731,26840,92157,60428,33230,64017,08498,68713,49314,99815,80515,21022,65421,04118,60021,79017,8230
       Other Current Liabilities 
0
100,800
100,800
118,680
118,680
407,991
409,384
292,109
306,002
230,607
71,441
199,961
113,794
95,323
70,829
114,137
126,705
129,321
124,037
164,256
179,977
150,803
138,656
277,855
147,141
171,237
153,494
432,362
265,132
278,608
289,310
457,850
301,993
299,411
273,648
406,212
309,667
334,654
333,295
52,000
52,000
52,000
52,000
32,250
32,250
12,500
12,500
12,500
221,502
260,053
234,961
454,950
325
325
57
427,053
427,05357325325454,950234,961260,053221,50212,50012,50012,50032,25032,25052,00052,00052,00052,000333,295334,654309,667406,212273,648299,411301,993457,850289,310278,608265,132432,362153,494171,237147,141277,855138,656150,803179,977164,256124,037129,321126,705114,13770,82995,323113,794199,96171,441230,607306,002292,109409,384407,991118,680118,680100,800100,8000
   > Long-term Liabilities 
0
758,061
758,191
694,785
731,082
712,680
705,800
886,937
869,835
913,974
623,084
768,398
736,177
916,925
887,042
871,449
871,833
859,785
832,972
817,293
644,399
430,175
408,466
52,973
52,713
262,075
258,279
232,255
232,230
211,154
202,955
176,818
175,683
152,744
149,665
126,581
124,242
114,669
114,524
88,600
88,593
105,557
105,595
99,339
100,930
115,730
115,849
109,163
140,342
133,123
132,138
126,502
126,796
196,376
196,762
190,409
190,409196,762196,376126,796126,502132,138133,123140,342109,163115,849115,730100,93099,339105,595105,55788,59388,600114,524114,669124,242126,581149,665152,744175,683176,818202,955211,154232,230232,255258,279262,07552,71352,973408,466430,175644,399817,293832,972859,785871,833871,449887,042916,925736,177768,398623,084913,974869,835886,937705,800712,680731,082694,785758,191758,0610
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,267
107,537
0
107,662
0
0
0
0
0000107,6620107,537108,267000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
803,359
816,521
811,700
808,645
802,344
822,452
838,077
861,346
928,024
1,284,595
1,255,065
1,286,623
1,425,594
1,420,645
1,395,704
1,424,162
1,441,398
1,534,260
1,533,881
1,770,318
1,994,318
2,061,049
2,001,169
2,049,526
2,123,140
2,188,251
2,062,185
2,095,967
2,143,215
2,180,860
2,049,335
2,059,246
2,053,137
2,088,595
2,009,752
2,070,184
2,187,278
2,250,226
2,121,909
2,151,299
2,204,529
2,249,312
2,141,988
2,187,416
2,240,207
2,281,229
2,174,056
2,248,659
2,411,029
2,504,941
2,365,282
2,411,904
2,377,103
2,229,817
2,273,951
2,273,9512,229,8172,377,1032,411,9042,365,2822,504,9412,411,0292,248,6592,174,0562,281,2292,240,2072,187,4162,141,9882,249,3122,204,5292,151,2992,121,9092,250,2262,187,2782,070,1842,009,7522,088,5952,053,1372,059,2462,049,3352,180,8602,143,2152,095,9672,062,1852,188,2512,123,1402,049,5262,001,1692,061,0491,994,3181,770,3181,533,8811,534,2601,441,3981,424,1621,395,7041,420,6451,425,5941,286,6231,255,0651,284,595928,024861,346838,077822,452802,344808,645811,700816,521803,3590
   Common Stock
0
630,008
630,008
630,008
630,008
630,008
630,008
630,008
630,008
647,877
746,948
784,748
792,933
833,309
833,309
891,641
891,641
891,641
899,629
899,629
951,256
1,002,498
1,002,852
1,005,958
1,007,915
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,885
1,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,009,8851,007,9151,005,9581,002,8521,002,498951,256899,629899,629891,641891,641891,641833,309833,309792,933784,748746,948647,877630,008630,008630,008630,008630,008630,008630,008630,0080
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
221
37,800
2,522
0
0
58,332
0
0
7,988
0
51,627
51,242
0
3,106
1,956
-22
-38
-29
-24
-17
-10
-8
-15
-14
-8
-10
-14
-17
-29
-34
-30
-30
203,658
222,550
222,548
222,548
222,550
242,276
242,277
242,333
242,278
277,532
277,533
277,532
277,532
297,371
297,371277,532277,532277,533277,532242,278242,333242,277242,276222,550222,548222,548222,550203,658-30-30-34-29-17-14-10-8-14-15-8-10-17-24-29-38-221,9563,106051,24251,62707,9880058,332002,52237,8002210000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
121,338
121,338
126,085
126,085
118,908
118,908
126,701
126,701
166,738
358,774
425,609
481,782
586,784
482,720
341,057
399,389
375,540
519,421
534,137
604,404
725,748
777,831
741,826
747,610
754,074
754,058
716,024
716,029
716,036
716,043
734,627
734,620
707,465
707,471
687,570
687,566
724,857
724,845
696,090
696,094
696,094
492,434
482,335
482,335
482,335
482,335
457,088
457,088
457,088
457,088
426,791
426,791
426,791
325,803
325,803
325,803325,803426,791426,791426,791457,088457,088457,088457,088482,335482,335482,335482,335492,434696,094696,094696,090724,845724,857687,566687,570707,471707,465734,620734,627716,043716,036716,029716,024754,058754,074747,610741,826777,831725,748604,404534,137519,421375,540399,389341,057482,720586,784481,782425,609358,774166,738126,701126,701118,908118,908126,085126,085121,338121,3380



6.3. Balance Sheets

Currency in TWD. All numbers in thousands.




6.4. Cash Flows

Currency in TWD. All numbers in thousands.




6.5. Income Statements

Currency in TWD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in TWD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,150,228
Cost of Revenue-1,394,665
Gross Profit755,563755,563
 
Operating Income (+$)
Gross Profit755,563
Operating Expense-495,652
Operating Income259,911259,911
 
Operating Expense (+$)
Research Development164,108
Selling General Administrative106,793
Selling And Marketing Expenses145,989
Operating Expense495,652416,890
 
Net Interest Income (+$)
Interest Income10,643
Interest Expense-7,182
Other Finance Cost-0
Net Interest Income3,461
 
Pretax Income (+$)
Operating Income259,911
Net Interest Income3,461
Other Non-Operating Income Expenses0
Income Before Tax (EBT)213,678306,144
EBIT - interestExpense = 292,565
213,678
205,591
Interest Expense7,182
Earnings Before Interest and Taxes (EBIT)299,747220,860
Earnings Before Interest and Taxes (EBITDA)481,585
 
After tax Income (+$)
Income Before Tax213,678
Tax Provision-15,269
Net Income From Continuing Ops198,409198,409
Net Income198,409
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,890,317
Total Other Income/Expenses Net-46,233-3,461
 

Technical Analysis of Nang Kuang Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nang Kuang Pharmaceutical Co Ltd. The general trend of Nang Kuang Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nang Kuang Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nang Kuang Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 44.50 < 44.50 < 45.05.

The bearish price targets are: 42.20 > 40.10 > 34.30.

Tweet this
Nang Kuang Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nang Kuang Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nang Kuang Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nang Kuang Pharmaceutical Co Ltd. The current macd is -0.06367796.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nang Kuang Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nang Kuang Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nang Kuang Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nang Kuang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNang Kuang Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nang Kuang Pharmaceutical Co Ltd. The current adx is 11.18.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nang Kuang Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Nang Kuang Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nang Kuang Pharmaceutical Co Ltd. The current sar is 42.20.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nang Kuang Pharmaceutical Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nang Kuang Pharmaceutical Co Ltd. The current rsi is 50.41. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Nang Kuang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartNang Kuang Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nang Kuang Pharmaceutical Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nang Kuang Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Nang Kuang Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartNang Kuang Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nang Kuang Pharmaceutical Co Ltd. The current cci is 67.37.

Nang Kuang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartNang Kuang Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nang Kuang Pharmaceutical Co Ltd. The current cmo is 6.11448248.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nang Kuang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNang Kuang Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nang Kuang Pharmaceutical Co Ltd. The current willr is -47.82608696.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nang Kuang Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Nang Kuang Pharmaceutical Co Ltd Daily Williams %R ChartNang Kuang Pharmaceutical Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nang Kuang Pharmaceutical Co Ltd.

Nang Kuang Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nang Kuang Pharmaceutical Co Ltd. The current atr is 0.53415166.

Nang Kuang Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartNang Kuang Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nang Kuang Pharmaceutical Co Ltd. The current obv is 174,649,165.

Nang Kuang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartNang Kuang Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nang Kuang Pharmaceutical Co Ltd. The current mfi is 44.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nang Kuang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartNang Kuang Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nang Kuang Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Nang Kuang Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nang Kuang Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.414
Ma 20Greater thanMa 5043.233
Ma 50Greater thanMa 10043.620
Ma 100Greater thanMa 20044.751
OpenGreater thanClose43.750
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Nang Kuang Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Nang Kuang Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nang Kuang Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nang Kuang Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nang Kuang Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nang Kuang Pharmaceutical Co Ltd.

Receive notifications about Nang Kuang Pharmaceutical Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.